Singapore: Amgen has terminated the partnership with AstraZeneca for co-development and commercialization of brodalumab,...
Singapore: Researchers at University of California, Los Angeles (UCLA), US, have reported the development of a molecular...
Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have c...
Singapore: US-based AVEO Oncology and Astellas Pharma have submitted a new drug application (NDA) to the US Food and Dru...
Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational ...
Singapore: NovaSAID, part of Sweden-based Karolinska Development, and India- based Cadila Pharmaceuticals have entered i...
Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk ...
Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine...
Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel a...
Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to ...
Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insuli...
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...
Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed t...
Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Therav...
Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastr...
Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in cert...
Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process ...
